Skip to main content

Advertisement

SpringerLink
Log in

Hypertension in Postmenopausal Women

  • SECONDARY HYPERTENSION: ADRENAL AND NERVOUS SYSTEM MECHANISMS (S OPARIL AND KH BERECEK, SECTION EDITORS)
  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

Blood pressure is typically lower in premenopausal women than in men. However, after menopause, the prevalence of hypertension in women is higher than it is in men. Hypertension is a major risk factor for cardiovascular disease in women and men, but cardiovascular disease is the leading cause of death in women. Furthermore, there is evidence that blood pressure may not be as well-controlled in women as in men, despite the fact that most women adhere better to their therapeutic regimens and medications than do men, and have their blood pressures measured more frequently than do men. This review describes possible mechanisms by which blood pressure may be increased in postmenopausal women.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Ong KL, Tso AWK, Lam KS, Cheung BM. Gender differences in BP control and cardiovascular risk factors in Americans with diagnosed hypertension. Hypertension. 2008;51:1142–8.

    Article  PubMed  CAS  Google Scholar 

  2. Wiinberg N, Høegholm A, Christensen HR, Bang LE, Mikkelsen KL, Nielsen PE, et al. 24-h ambulatory BP in 352 normal Danish subjects, related to age and gender. Am J Hypertension. 1995;8:978–86.

    Article  CAS  Google Scholar 

  3. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population. results from the Third National Health and Nutrition Examination Survey, 1988–1991. Hypertension. 1995;25:305–13.

    PubMed  CAS  Google Scholar 

  4. •• National Center for Health and Statistics Health, United States, 2010, with special feature on death and dying. Hyattsville, MD, Data Tables, pg 67, 2011. This publication contains the most recent national statistics and data on cardiovascular disease and obesity and thus is an excellent resource.

  5. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension; analysis of worldwide data. Lancet. 2005;365:217–23.

    PubMed  Google Scholar 

  6. Taddei S. BP through aging and menopause. Climacteric. 2009;12 Suppl 1:36–40.

    Article  PubMed  Google Scholar 

  7. Pérez-López FR, Chedraui P, Gilbert JJ, Pérez-Roncero G. Cardiovascular risk in menopausal women and prevalent related co-morbid conditions: facing the post-Women’s Health Initiative era. Fertil Steril. 2009;92:1171–86.

    Article  PubMed  Google Scholar 

  8. Sjoberg L, Kaaja R, Tuomilehto J. Epidemiology of postmenopausal hypertension. Int J Clin Pract Suppl. 2004;139:4–12.

    PubMed  Google Scholar 

  9. Kim JK, Alley D, Seeman T, Karlamangla A, Crimmins E. Recent changes in cardiovascular risk factors among women and men. J Women’s Health (Larchmont). 2006;15:734–46.

    Article  Google Scholar 

  10. Routledge FS, McFetridge-Durdle JA, Dean CR. Stress, menopausal status and nocturnal BP dipping patterns among hypertensive women. Can J Cardiol. 2009;25:e157–63.

    Article  PubMed  Google Scholar 

  11. Stolarz K, Staessen JA, O’Brien ET. Night-time BP: dipping into the future? J Hypertension. 2002;21:2131–3.

    Article  Google Scholar 

  12. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, et al. An independent predictor of prognosis in essential hypertension. Hypertension. 1994;24:793–801.

    PubMed  CAS  Google Scholar 

  13. Ben-Dov IZ, Kark JD, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M. Predictors of all-cause mortality in clinical ambulatory monitoring. Unique aspects of BP during sleep. Hypertension. 2007;49:235–1241.

    Article  Google Scholar 

  14. Schunkert H, Danser AH, Hense HW, Derkx FH, Kurzinger S, Riegger GA. Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circ. 1997;95:39–45.

    CAS  Google Scholar 

  15. Fernandez-Vega F, Abellan J, Vegazo O, De Vinuesa SG, Rodriguez JC, Maceira B, et al. Angiotensin II type 1 receptor blockade to control BP in postmenopausal women: influence of hormone replacement therapy. Kidney Int 2002, Suppl: S36–41.

  16. Mansego ML, Redon J, Marin R, González-Albert V, Martin-Escudero JC, Fabia MJ, et al. Renin polymorphisms and haplotypes are associated with BP levels and hypertension risk in postmenopausal women. J Hypertension. 2008;26:230–7.

    Article  CAS  Google Scholar 

  17. Yanes LL, Romero DG, Iliescu R, Zhang H, Davis D, Reckelhoff JF. Postmenopausal hypertension: role of the renin-angiotensin system. Hypertension. 2010;56(3):359–63.

    Article  PubMed  CAS  Google Scholar 

  18. Alexander BT, Cockrell KL, Rinewalt AN, Herrington JN, Granger JP. Enhanced renal expression of preproendothelin mRNA during chronic angiotensin II hypertension. Am J Physiol Regul Integr Comp Physiol. 2001;280:R1388–92.

    PubMed  CAS  Google Scholar 

  19. Wilkins Jr FC, Alberola A, Mizelle HL, Opgenorth TJ, Granger JP. Systemic hemodynamics and renal function during long-term pathophysiological increases in circulating endothelin. Am J Physiol. 1995;268:R375–81.

    PubMed  CAS  Google Scholar 

  20. Mortensen LH, Pawloski CM, Kanagy NL, Fink GD. Chronic hypertension produced by infusion of endothelin in rats. Hypertension. 1990;15:729–33.

    PubMed  CAS  Google Scholar 

  21. Komatsumoto S, Nara M. Changes in the level of endothelin-1 with aging. Nippon Ronen Igakkai Zasshi. 1995;32:664–9.

    Article  PubMed  CAS  Google Scholar 

  22. Ballew JR, Fink GD. Role of ET(A) receptors in experimental Ang II-induced hypertension in rats. Am J Physiol Regul Integr Comp Physiol. 2001;281:R150–4.

    PubMed  CAS  Google Scholar 

  23. Ballew JR, Fink GD. Role of endothelin ETB receptor activation in angiotensin II-induced hypertension: effects of salt intake. Am J Physiol Heart Circ Physiol. 2001;281:H2218–25.

    PubMed  CAS  Google Scholar 

  24. Yanes LL, Romero DG, Cucchiarelli VE, Fortepiani LA, Gomez-Sanchez CE, Santacruz F, et al. Role of endothelin in mediating postmenopausal hypertension in a rat model. Am J Physiol Regul Integr Comp Physiol. 2005;288:R229–33.

    Article  PubMed  CAS  Google Scholar 

  25. Sasser JM, Pollock JS, Pollock DM. Renal endothelin in chronic angiotensin II hypertension. Am J Physiol Regul Integr Comp Physiol. 2002;283:R243–8.

    PubMed  CAS  Google Scholar 

  26. de Kraker AT, Kenemans P, Smolders RG, Kroeks MV, van der Mooren MJ. Short-term effects of continuous combined oestrogen-progestogen therapy on several cardiovascular risk markers in healthy postmenopausal women; a randomized control trial. Eur J Obstet Gynecol Reprod Biol. 2009;142:139–44.

    Article  PubMed  Google Scholar 

  27. Polderman KH, Stehouwer CD, van Kamp GJ, Dekker GA, Verheugt FW, Gooren LJ. Influence of sex hormones on plasma endothelin levels. Ann Intern Med. 1993;118:429–32.

    PubMed  CAS  Google Scholar 

  28. van Kesteren PJ, Kooistra T, Lansink M, van Kamp JG, Asscheman H, Gooren LJ, et al. The effects of sex steroids on plasma levels of marker proteins of endothelial cell functioning. Thromb Haemost. 1998;79:1029–33.

    PubMed  Google Scholar 

  29. Chen Y-F, Naftilan AJ, Oparil S. Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats. Hypertension. 1992;19:456–63.

    PubMed  CAS  Google Scholar 

  30. Ellison KE, Ingelfinger JR, Pivor M, Dzau VJ. Androgen regulation of rat renal angiotensinogen messenger RNA expression. J Clin Invest. 1989;83:1941–5.

    Article  PubMed  CAS  Google Scholar 

  31. Romero JC, Reckelhoff JF. Role of angiotensin and oxidative stress in essential hypertension. Hypertension. 1999;34:943–9.

    PubMed  CAS  Google Scholar 

  32. Reckelhoff JF, Romero JC. Role of oxidative stress in angiotensin-induced hypertension. Am J Physiol Regul Integr Comp Physiol. 2003;284:R893–912.

    PubMed  CAS  Google Scholar 

  33. Estaban Castelao J, Gago-Dominguez M. Risk factors for cardiovascular disease in women: relationship to lipid peroxidation and oxidative stress. Med Hypotheses. 2008;71:39–44.

    Article  Google Scholar 

  34. Sartori-Valinotti JC, Iliescu R, Fortepiani LA, Yanes LL, Reckelhoff JF. Sex differences in oxidative stress and the impact on blood pressure control and cardiovascular disease. Clin Exp Pharm Physiol. 2007;34:938–45.

    Article  PubMed  CAS  Google Scholar 

  35. Pechanova O, Simko F. Chronic antioxidant therapy fails to ameliorate hypertension: potential mechanisms behind. J Hypertension Suppl. 2009;27:S32–6.

    Article  CAS  Google Scholar 

  36. McQueen MJ, Lonn E, Gerstein HC, Bosch J, Yusuf S. The HOPE (Heart Outcomes Prevention Evaluation) study and its consequences. Scand J Clin Lab Invest Suppl. 2005;240:143–56.

    Article  PubMed  CAS  Google Scholar 

  37. Yanes L, Romero D, Iliescu R, Cucchiarelli VE, Fortepiani LA, Santacruz F, et al. Systemic arterial pressure response to two weeks of Tempol therapy in SHR: involvement of NO, the RAS, and oxidative stress. Am J Physiol Regul Integr Comp Physiol. 2005;288:R229–33.

    Google Scholar 

  38. Ford ES, Li C, Zhao G, Tsai J. Trends in obesity and abdominal obesity among adults in the United States from 1999 to 2008. Int J Obes (Lond). 2011;35:736–43.

    Article  CAS  Google Scholar 

  39. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999–2008. JAMA. 2010;303:235–41.

    Article  PubMed  CAS  Google Scholar 

  40. Lobo RA. Metabolic syndrome after menopause and the role of hormones. Maturitas. 2008;60:10–8.

    Article  PubMed  CAS  Google Scholar 

  41. Ozbey N, Sencer E, Molvalillar S, Orhan Y. Body fat distribution and cardiovascular disease risk factors in pre- and post-menopausal obese women with similar BMI. Endocrinol J. 2002;49:503–9.

    Google Scholar 

  42. Wildman RP, McGinn AP, Lin J, Wang D, Muntner P, Cohen HW, et al. Cardiovascular disease risk of abdominal obesity vs metabolic abnormalities. Obesity (Silver Spring). 2011;19:853–60.

    Article  Google Scholar 

  43. Rossi R, Nuzzo A, Origliani G, Modena MG. Metabolic syndrome affects cardiovascular risk profile and response to treatment in hypertensive postmenopausal women. Hypertension. 2008;52:865–72.

    Article  PubMed  CAS  Google Scholar 

  44. de Belin de Chantemèle EJ, Mintz JD, Rainey WE, Stepp DW. Impact of leptin-mediated sympatho-activation on cardiovascular function in obese mice. Hypertension. 2011;58:271–9.

    Article  PubMed  Google Scholar 

  45. • Hall JE, da Silva AA, do Carmo JM, Dubinion J, Hamza S, Munusamy S, et al. Obesity-induced hypertension: role of sympathetic nervous system, leptin and melanocortins. J Biol Chem. 2010;85:17271–6. This review describes the roles played by leptin and the MC4 receptor in mediating increased sympathetic activity in obesity.

    Article  Google Scholar 

  46. Esler MD, Elkelis N, Lambert E, Straznicky N. Neural mechanisms and management of obesity-related hypertension. Curr Cardiol Rep. 2008;10:456–63.

    Article  PubMed  Google Scholar 

  47. Kassab S, Kato T, Wilkins FC, Chen R, Hall JE, Granger JP. Renal denervation attenuates sodium retention and hypertension associated with obesity. Hypertension. 1995;25:893–7.

    PubMed  CAS  Google Scholar 

  48. Haynes WG, Morgan DA, Djalali A, Sivitz WI, Mark AL. Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension. 1999;33:542–7.

    PubMed  CAS  Google Scholar 

  49. Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension. 1998;31:409–14.

    PubMed  CAS  Google Scholar 

  50. Hall JE, Hildebrandt DA, Kuo J. Obesity hypertension: role of leptin and sympathetic nervous system. Am J Hypertens. 2001;14:103S–15S.

    Article  PubMed  CAS  Google Scholar 

  51. Hogarth AJ, Burns J, Mckintosh AF, Mary DA. Sympathetic nerve hyperactivity of essential hypertension is lower in postmenopausal women than men. J Hum Hypertension. 2008;22:544–9.

    Article  CAS  Google Scholar 

  52. Czarnecka D, Pośnik-Urbańska A, Kawecka-Jaszcz K, Kolasińska-Kloch W, Wojciechowska W, Fedak D. Indices of autonomic nervous system activity in women with mild hypertension in the perimenopausal period. Kardiol Pol. 2009;67:243–51.

    PubMed  Google Scholar 

  53. Olszanecka A, Pośnik-Urbańska A, Kawecka-Jaszcz K, Czarnecka D, Fedak D. Adipocytokines and BP, lipids and glucose metabolism in hypertensive perimenopausal women. Kardiolo Pol. 2010;68:753–60.

    Google Scholar 

  54. Pelzer T, de Jager T, Muck J, Stimpel M, Neyses L. Oestrogen action on the myocardium in vivo: specific and permissive for angiotensin-converting enzyme inhibition. J Hypertens. 2002;20:1001–6.

    Article  PubMed  CAS  Google Scholar 

  55. Affinito P, Palomba S, Bonifacio M, Fontana D, Izzo R, Trimarco B, et al. Effects of hormone replacement therapy in postmenopausal hypertensive patients. Maturitas. 2001;40:75–83.

    Article  PubMed  CAS  Google Scholar 

  56. Dubey RK, Oparil S, Imthurm B, Jackson EK. Sex hormones and hypertension. Cardiovasc Res. 2002;53:688–708.

    Article  PubMed  CAS  Google Scholar 

  57. Nickenig G, Bäumer AT, Grohè C, Kahlert S, Strehlow K, Rosenkranz S, et al. Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circ. 1998;97:2197–201.

    CAS  Google Scholar 

  58. • Langrish JP, Mills NL, Bath LE, Warner P, Webb DJ, Kelnar CJ, et al. Cardiovascular effects of physiological and standard sex steroid replacement regimens in premature ovarian failure. Hypertension. 2009;53:805–11. This publication shows that women 18 to 41 years of age who had premature ovarian failure and were treated with HRT did not have the cardiovascular side effects that women in the WHI cohort experienced. These data support the notion that changes in response to estrogens occur with aging.

    Article  PubMed  CAS  Google Scholar 

  59. Burry KA. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women’s Health Initiative randomized controlled trial. Curr Women’s Health Rep. 2002;2:331–2.

    Google Scholar 

  60. Herrington DM. The HERS trial results: paradigms lost? Heart and Estrogen/progestin Replacement Study. Ann Int Med. 1999;131:463–6.

    PubMed  CAS  Google Scholar 

  61. Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA. 2002;288:49–57.

    Article  PubMed  Google Scholar 

  62. Cacciatore B, Paakkari I, Hasselblatt R, Nieminen MS, Toivonen J, Tikkanen MI, et al. Randomized comparison between orally and transdermally administered hormone replacement therapy regimens of long-term effects on 24-hr ambulatory BP in postmenopausal women. Am J Obstet Gynecol. 2001;184:904–9.

    Article  PubMed  CAS  Google Scholar 

  63. Manhem K, Ahlm H, Milson I, Svensson A. Transdermal oestrogen reduces daytime BP in hypertensive women. J Hum Hypertens. 1998;12:323–7.

    Article  PubMed  CAS  Google Scholar 

  64. Seely EW, Walsh BW, Gerhard MD, Williams GH. Estradiol with or without progesterone and ambulatory BP in postmenopausal women. Hypertension. 1999;33:1190–4.

    PubMed  CAS  Google Scholar 

  65. Kaya C, Cengiz SD, Cengiz B, Akgun G. Long-term effects of low dose 17beta-estradiol plus dydrogesterone on 24-hr ambulatory BP in healthy postmenopausal women: a 1 year, randomized, prospective study. Gynecol Endocrinol. 2007;23 Suppl 1:62–7.

    Article  PubMed  CAS  Google Scholar 

  66. Mortensen KH, Hansen KW, Erlandsen M, Christiansen JS, Gravholt CH. Ambulatory arterial stiffness index in Turner syndrome: the impact of sex hormone therapy. Horm Res. 2009;72:184–9.

    Article  PubMed  CAS  Google Scholar 

  67. de Carvalho MN, Nobre F, Mendes MC, Dos Reis RM, Ferriani RA, Silva de Sá MF. Low-dose transdermal hormone therapy does not interfere with the BP of hypertensive menopausal women: a pilot study. Blood Press Monit. 2008;13:277–83.

    Article  PubMed  Google Scholar 

  68. Ichikawa A, Sumino H, Ogawa T, Ichikawa S, Nitta K. Effects of long term transdermal hormone replacement therapy on the renin-angiotensin-aldosterone system, plasma bradykinin levels and BP in normotensive postmenopausal women. Geriatr Gerontol Int. 2008;8:259–64.

    Article  PubMed  Google Scholar 

  69. Prelevic GM, Kwong P, Byrne DJ, Jagroop IA, Ginsburg J, Mikhailidis DP. A cross-sectional study of the effect of hormone replacement therapy on cardiovascular disease risk profile in healthy postmenopausal women. Fertil Steril. 2002;77:945–51.

    Article  PubMed  Google Scholar 

  70. Harman SM, Vittinghoff E, Brinton EA, Budoff MJ, Cedars MI, Lobo RA, et al. Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes. Am J Med. 2011;124:199–205.

    Article  PubMed  CAS  Google Scholar 

  71. Taddei S, Virdis A, Ghiadooni L, Mattei P, Sudano I, Bernini G, et al. Menopause is associated with endothelial dysfunction in women. Hypertension. 1996;28:576–82.

    PubMed  CAS  Google Scholar 

  72. Rossi R, Nuzzo A, Origliani G, Modena MG. Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women. J Am Coll Card. 2008;51:997–1002.

    Article  Google Scholar 

  73. Kalantaridou SN, Naka KK, Papanikolaou E, Kazakos N, Kravariti M, Calis KA, et al. Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. J Clin Endocrinol Metab. 2004;89:3907–13.

    Article  PubMed  CAS  Google Scholar 

  74. Kelemen M, Vaidya D, Waters DD, Howard BV, Cobb F, Younes N, et al. Hormone therapy and antioxidant vitamins do not improve endothelial vasodilator function in postmenopausal women with established coronary artery disease: a substudy of the Women’s Angiographic Vitamin and Estrogen (WAVE) trial. Atherosclerosis. 2005;179:193–200.

    Article  PubMed  CAS  Google Scholar 

  75. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA. 1994;91:5212–6.

    Article  PubMed  CAS  Google Scholar 

  76. Wyatt AW, Steinert JR, Mann GE. Modulation of the L-arginine/nitric oxide signalling pathway in vascular endothelial cells. Biochem Soc Symp. 2004;71:143–56.

    PubMed  CAS  Google Scholar 

  77. Iñarrea P, Casanova A, Alava MA, Iturralde M, Cadenas E. Melatonin and steroid hormones activate intermembrane Cu, Zn-superoxide dismutase by means of mitochondrial cytochrome P450. Free Radic Biol Med. 2011;50:1575.

    Article  PubMed  Google Scholar 

  78. Gallagher PE, Li P, Lenhart JR, Chappell MC, Brosnihan KB. Estrogen regulation of angiotensin-converting enzyme mRNA. Hypertension. 1999;33:323–8.

    PubMed  CAS  Google Scholar 

  79. Schunkert H, Danser AH, Hense HW, Derkx FH, Kürzinger S, Riegger GA. Effects of estrogen replacement therapy on the renin-angiotensin system in post-menopausal women. Circ. 1997;95:39–45.

    CAS  Google Scholar 

  80. Wassmann K, Ghiassi A, Wassmann S, Böhm M, Nickenig G. AT1 Receptor antagonism improves endothelial dysfunction in postmenopausal women. Maturitas. 2006;53(2):176–83.

    Article  PubMed  CAS  Google Scholar 

  81. Diamanti-Kandarakis E. Polycystic ovarian syndrome; pathophysiology, molecular aspects and clinical implications. Exp Rev Mol Med. 2008;10:1–21.

    Article  Google Scholar 

  82. Chen M-J, Yang W-S, Yang J-H, Chen C-L, Ho H-N, Yang Y-S. Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome. Hypertension. 2007;49:1442–7.

    Article  PubMed  CAS  Google Scholar 

  83. Shaw LJ, Bairey Merz CN, Azziz R, Stanczyk FZ, Sopko G, Braunstein GD, et al. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from NIH-NHLBI Sponsored Women’s Ischemia Syndrome Evaluation. J Clin Endocrinol Metab. 2008;93:1276–84.

    Article  PubMed  CAS  Google Scholar 

  84. Laughlin GA, Barrett-Connor E, Kritz-Silverstein D, von Mühlen D. Hysterectomy, oophorectomy and endogenous sex hormones levels in older women: the Rancho Bernardo study. J Endocrinol Metab. 2000;85:645–51.

    Article  CAS  Google Scholar 

  85. Krug E, Berga SL. Postmenopausal hyperthecosis: function dysregulation of androgenesis in climacteric ovary. Obstet Gynecol. 1999;99:893–7.

    Article  Google Scholar 

  86. Bui HN, Struys EA, Martens F, de Ronde W, Thienpont LM, Kenemans P, et al. Serum testosterone levels measured by isotope dilution-liquid chromatography-tandem mass spectrometry in postmenopausal women versus those in women who underwent bilateral oophorectomy. Ann Clin Biochem. 2010;47:248–52.

    Article  PubMed  CAS  Google Scholar 

  87. Quinkler M, Bumke-Vogt C, Meyer B, Bähr V, Oelkers W, Diederich S. The human kidney is a progesterone-metabolizing and androgen-producing organ. J Clin Endocrin Metab. 2003;88:2803–9.

    Article  CAS  Google Scholar 

  88. Lukanova A, Lundin E, Zeleniuch-Jacquotte A, Muti P, Mure A, Rinaldi S, et al. Body mass index, circulating levels of sex steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. Eur J Endocrinol. 2004;150:161–71.

    Article  PubMed  CAS  Google Scholar 

  89. Malkin CJ, Pugh PJ, Jones RD, Kapoor D, Channer KS, Jones TH. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J Clin Endocrinol Metab. 2004;89:3313–8.

    Article  PubMed  CAS  Google Scholar 

  90. Stanworth RD, Jones TH. Testosterone in obesity, metabolic syndrome and type 2 diabetes. Front Horm Res. 2009;37:74–90.

    Article  PubMed  CAS  Google Scholar 

  91. Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type II diabetes: a systematic review and meta-analysis. JAMA. 2006;295:1288–99.

    Article  PubMed  CAS  Google Scholar 

  92. Steiner M, Dunn E, Born L. Hormones and mood: from menarche to menopause and beyond. J Affect Disord. 2003;74:67–83.

    Article  PubMed  CAS  Google Scholar 

  93. Goldstein BI, Fagiolini A, Houck P, Kupfer DJ. Cardiovascular disease and hypertension among adults with bipolar disorder in the United States. Bipolar Disord. 2009;11:657–62.

    Article  PubMed  Google Scholar 

  94. Lambert E, Dawood T, Straznicky N, Sari C, Schlaich M, Esler M, et al. Association between the sympathetic firing pattern and anxiety level in patients with metabolic syndrome and elevated BP. J Hypertension. 2010;28:543–50.

    Article  CAS  Google Scholar 

  95. García-Vera MP, Sanz J, Espinosa R, Fortún M, Magán I. Differences in emotional personality traits and stress between sustained hypertension and normotension. Hypertension Res. 2010;33:203–8.

    Article  Google Scholar 

  96. Braszko JJ, Karwowska-Polecka W, Halicka D, Gard PR. Captopril and enalapril improve cognition and depressed mood in hypertensive patients. J Basic Clin Physiol Pharmacol. 2003;14:323–43.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors acknowledge the support of National Institutes of Health grants RO1s HL66072 and HL69194 and PO1 HL51971 (to Dr. Reckelhoff).

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Department of Physiology and Biophysics, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS, 39216-4505, USA

    Roberta Lima, Marion Wofford & Jane F. Reckelhoff

Authors
  1. Roberta Lima
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marion Wofford
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jane F. Reckelhoff
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jane F. Reckelhoff.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lima, R., Wofford, M. & Reckelhoff, J.F. Hypertension in Postmenopausal Women. Curr Hypertens Rep 14, 254–260 (2012). https://doi.org/10.1007/s11906-012-0260-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-012-0260-0

Keywords

Search

Navigation